ANGANY is a private, early clinical stage pharmaceutical company, based in Lévis, QC, Canada. ANGANY has tackled the specific challenges of allergy to invent a novel class of biologics. ANGANY has developed an exclusive therapeutic platform based on synthetic biology: the eBioparticle ™, a self-adjuvant vector bringing novel features of safety and potent immunomodulation to thwart allergy.
| Website | http://www.angany.com |
| Revenue | $2 million |
| Employees | 11 (11 on RocketReach) |
| Founded | 2017 |
| Address | 873 Rue St-Jean, 200, Québec, Québec G1R 1R2, CA |
| Phone | +33 2 32 59 05 80 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Research, Pharmaceutical, First In Class, Allergy Treatment, Platform Technology, Drug Development, Personalized Medicine, Biotechnology, Immunotherapy, Clinical Trials, Drug Discovery, Life Sciences, Therapeutics, Biopharma, Health Technology, Medical Research, Innovation |
| Competitors | Milan Laser Hair Removal, Ideal Image, LaserAway, SkinSpirit, Smooth Skin, American Laser Skincare, Lumenis, Aesthetica Medical Spa, MyEllevate®, Sofwave +22 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular ANGANY employee's phone or email?
The ANGANY annual revenue was $2 million in 2026.
Christine Guillen is the CEO and PDG of ANGANY.
11 people are employed at ANGANY.
ANGANY is based in Québec, Québec.
The NAICS codes for ANGANY are [32541, 3254, 32, 325].
The SIC codes for ANGANY are [28, 283].